AUA Guidelines for Metastatic Castration-Resistant Prostate Cancer

“The American Urological Association recently released its first set of treatment guidelines addressing the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) at its 2013 Annual Meeting. The guidelines were released to address the increasingly complex treatment landscape available for patients with mCRPC. According to the guideline, prior to 2004, patients with mCRPC who failed primary androgen therapy were treated only for palliation.”